Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Reply to Karadag: does steroid increase LPS-induced sickness behaviors?
    Published on 2024-03-12
    2 years ago
  • Brain-based graph-theoretical predictive modeling to map the trajectory of anhedonia, impulsivity, and hypomania from the human functional connectome
    Published on 2024-03-12
    2 years ago
  • Lifespan development of thalamic nuclei and characterizing thalamic nuclei abnormalities in schizophrenia using normative modeling
    Published on 2024-03-12
    2 years ago
  • Elevated dorsal medial prefrontal cortex to lateral habenula pathway activity mediates chronic stress-induced depressive and anxiety-like behaviors
    Published on 2024-03-12
    2 years ago
  • Clinical decision support for bipolar depression using large language models
    Published on 2024-03-12
    2 years ago
  • Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression
    Published on 2024-03-11
    2 years ago
  • Late-adolescent onset of prefrontal endocannabinoid control of hippocampal and amygdalar inputs and its impact on trace-fear conditioning behavior
    Published on 2024-03-10
    2 years ago
« Previous 1 … 94 95 96 97 98 … 143 Next »
Journal of Psychopharmacology
  • Evidence for the atherogenic index of plasma as a potential biomarker for cardiovascular disease in schizophrenia
    Published on 2021-06-26
    5 years ago
  • Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
    Published on 2021-06-26
    5 years ago
  • Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019
    Published on 2021-06-05
    5 years ago
  • Psychedelics and health behaviour change
    Published on 2021-05-29
    5 years ago
  • 5-HT1B receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats
    Published on 2021-05-29
    5 years ago
  • Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis
    Published on 2021-05-29
    5 years ago
  • Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
    Published on 2021-05-28
    5 years ago
« Previous 1 … 94 95 96 97 98 … 150 Next »
European Neuropsychopharmacology
  • Influence of pre-treatment structural brain measures on effects of action-based cognitive remediation on executive function in partially or fully remitted patients with bipolar disorder
    Published on 2021-12-20
    5 years ago
  • COVID-19 and Behavioral Addictions: Worrying consequences?
    Published on 2021-12-17
    5 years ago
  • A review and meta-analysis of gene expression profiles in suicide
    Published on 2021-12-17
    5 years ago
  • Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls
    Published on 2021-12-17
    5 years ago
  • Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants – Author’s reply
    Published on 2021-12-06
    5 years ago
  • Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression
    Published on 2021-11-28
    5 years ago
  • A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
    Published on 2021-11-27
    5 years ago
« Previous 1 … 94 95 96 97 98 … 168 Next »

   Pharma Pub